A retrospective study revealed that patients who tested positive for HLA-B*35 and HLA-DRB1*11 molecules presented a significantly elevated risk of developing CIP (39). The gene discussed is HLA-DRB1; the disease is hereditary sensory and autonomic neuropathy.